Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


StarCaps shipping stopped

This article was originally published in The Tan Sheet

Executive Summary

Los Angeles-based marketer Nikki Haskell suspends shipping the weight-loss supplement after a National Football League player alleged Oct. 28 that the product was tainted with bumetanide, a diuretic the NFL banned because it may mask steroid use. In an e-mail, StarCaps said it is aware of the lawsuit filed in New Jersey federal court by New Orleans Saints player Jamar Nesbit and is taking steps to ensure customers receive a safe and effective product. Nesbitt served a four-game suspension after he tested positive for the banned substance. Nesbitt did not appeal the suspension, but another Saints player who also tested positive for bumetanide after using StarCaps is appealing his suspensions. According to ads, StarCaps contains papaya, garlic, valerian, corn spices, papain, magnesium carbonate and magnesium oxide. Nesbitt's lawsuit comes as Congress presses for tighter regulation of supplements, partly due to athletes' complaints about products tainted with steroid ingredients. Industry says supplements are a scapegoat for intentional steroid use

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts